Advertisement

Table of Contents

March 01, 1993; Volume 43,Issue 3

You have access
Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
H Matthes, U Boschert, N Amlaiky, R Grailhe, J L Plassat, F Muscatelli, M G Mattei and R Hen

Molecular Pharmacology March 1993, 43 (3) 313-319;
You have access
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
F J Monsma, Y Shen, R P Ward, M W Hamblin and D R Sibley

Molecular Pharmacology March 1993, 43 (3) 320-327;
You have access
Expression of multiple forms of cytochrome P450 mRNAs in primary cultures of rat hepatocytes maintained on matrigel.
T A Kocarek, E G Schuetz and P S Guzelian

Molecular Pharmacology March 1993, 43 (3) 328-334;
You have access
N-hydroxylation of benzamidine to benzamidoxime by a reconstituted cytochrome P-450 oxidase system from rabbit liver: involvement of cytochrome P-450 IIC3.
B Clement, F Jung and H Pfunder

Molecular Pharmacology March 1993, 43 (3) 335-342;
You have access
Lack of beta 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human.
R F Thomas and S B Liggett

Molecular Pharmacology March 1993, 43 (3) 343-348;
You have access
Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation.
J Akiyoshi, C Hough and D M Chuang

Molecular Pharmacology March 1993, 43 (3) 349-355;
You have access
Presence of m3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in the cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line.
T Kaneda, Y Kitamura and Y Nomura

Molecular Pharmacology March 1993, 43 (3) 356-364;
You have access
Histamine-induced production of interleukin-1 alpha from murine bone marrow stromal cells and its inhibition by H2 blockers.
K Tasaka, M Mio, M Shimazawa and N Nakaya

Molecular Pharmacology March 1993, 43 (3) 365-371;
You have access
Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
C Rohlff, B Safa, A Rahman, Y S Cho-Chung, R W Klecker and R I Glazer

Molecular Pharmacology March 1993, 43 (3) 372-379;
You have access
A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase.
E A Austin and B E Huber

Molecular Pharmacology March 1993, 43 (3) 380-387;
You have access
Further characterization and purification of the flavin-dependent S-benzyl-L-cysteine S-oxidase activities of rat liver and kidney microsomes.
P J Sausen, R J Duescher and A A Elfarra

Molecular Pharmacology March 1993, 43 (3) 388-396;
You have access
Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model.
D Stickle and R Barber

Molecular Pharmacology March 1993, 43 (3) 397-411;
You have access
Human S31 serotonin receptor clone encodes a 5-hydroxytryptamine1E-like serotonin receptor.
T Gudermann, F O Levy, M Birnbaumer, L Birnbaumer and A J Kaumann

Molecular Pharmacology March 1993, 43 (3) 412-418;
You have access
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
D B Wainscott, M L Cohen, K W Schenck, J E Audia, J S Nissen, M Baez, J D Kursar, V L Lucaites and D L Nelson

Molecular Pharmacology March 1993, 43 (3) 419-426;
You have access
Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
N Adham, B Ellerbrock, P Hartig, R L Weinshank and T Branchek

Molecular Pharmacology March 1993, 43 (3) 427-433;
You have access
Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
D Graeser and R R Neubig

Molecular Pharmacology March 1993, 43 (3) 434-443;
You have access
Characterization of alpha 2-adrenergic receptor subtype-specific antibodies.
H Kurose, J L Arriza and R J Lefkowitz

Molecular Pharmacology March 1993, 43 (3) 444-450;
You have access
Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
M A Debernardi, R Munshi and G Brooker

Molecular Pharmacology March 1993, 43 (3) 451-458;
You have access
Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states.
R A Hall, G Massicotte, M Kessler, M Baudry and G Lynch

Molecular Pharmacology March 1993, 43 (3) 459-464;
You have access
Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells.
B D Carter and F Medzihradsky

Molecular Pharmacology March 1993, 43 (3) 465-473;
You have access
Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
U Quast, K M Bray, H Andres, P W Manley, Y Baumlin and J Dosogne

Molecular Pharmacology March 1993, 43 (3) 474-481;
You have access
Modulation of gating of cloned rat and human K+ channels by micromolar Zn2+.
N L Harrison, H K Radke, M M Tamkun and D M Lovinger

Molecular Pharmacology March 1993, 43 (3) 482-486;
You have access
Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain.
J P Bolaños and J M Medina

Molecular Pharmacology March 1993, 43 (3) 487-490;
You have access
Cisplatin inhibits in vitro translation by preventing the formation of complete initiation complex.
J M Rosenberg and P H Sato

Molecular Pharmacology March 1993, 43 (3) 491-497;